Revised forecast
Fiscal year ending October 2026 · Full yearPrevious forecast published 12 December 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Sales increased in the Agricultural Chemicals and Agriculture-Related Businesses and the Fine Chemicals Business. Operating profit declined due to the recognition of inventory valuation losses resulting from lower market prices following generic competition with the overseas herbicide 「アクシーブ」. The decline in ordinary profit narrowed due to higher equity-method investment gains and foreign exchange gains from the weaker yen. Net income declined mainly because of extraordinary losses, including impairment losses on fixed assets and restructuring costs.
Extraordinary losses, including impairment losses on fixed assets and restructuring costs. Amount: Not disclosed
| Item | Details |
|---|---|
| Net Sales | ¥162,000 million → ¥175,000 million（+8.0%） |
| Operating profit | ¥7,200 million → ¥2,700 million（-62.5%） |
| Ordinary income | ¥10,900 million → ¥8,500 million（-22.0%） |
| Profit attributable to owners of the parent | ¥6,400 million → ¥4,000 million（-37.5%） |
| Net income per share | 53.15 yen and sen → 33.2 yen and sen |
| Fiscal Period Covered | Fiscal year ending October 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 12 December 2025 |
| Previous-period results | Revenue: ¥170,462 million; operating profit: ¥10,567 million; ordinary profit: ¥13,363 million; net income attributable to owners of the parent: ¥4,381 million; basic earnings per share: ¥36.38 |
| Reason for the revision | Sales increased in the Agricultural Chemicals and Agriculture-Related Businesses and the Fine Chemicals Business. Operating profit declined due to the recognition of inventory valuation losses resulting from lower market prices following generic competition with the overseas herbicide 「アクシーブ」. The decline in ordinary profit narrowed due to higher equity-method investment gains and foreign exchange gains from the weaker yen. Net income declined mainly because of extraordinary losses, including impairment losses on fixed assets and restructuring costs. |
| Details and amount of extraordinary loss | Extraordinary losses, including impairment losses on fixed assets and restructuring costs. Amount: Not disclosed |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales are expected to increase in the Agricultural Chemicals and Agriculture-Related Businesses and the Fine Chemicals Business, with revenue expected to exceed the forecast. Operating profit is expected to decline due to the recognition of inventory valuation losses resulting from lower market prices following generic competition with the overseas herbicide 「アクシーブ」, among other factors. The decline in ordinary profit is expected to narrow due to higher equity-method investment gains and foreign exchange gains from the weaker yen, while net income is expected to decline mainly because of extraordinary losses, including impairment losses on fixed assets and restructuring costs.